EAT Announced Acquisition of Green Therapeutics in Nevada About Green Therapeutics
Green Therapeutics is one of Nevada’s premier innovators and established producer/processors. They operate a state-of-the-art cultivation and processing facility in the Las Vegas area, producing and selling cannabis flower and manufactured cannabis products to dispensaries across the State. In addition, they also manufacture the following products: dabs, vape pens and cartridges, oral sprays, topical creams, as well as pre-rolls.
Green Therapeutics’ asset base includes:
- Four Nevada Licenses: 2 cultivation and 2 production facilities in Clark County & North Las Vegas;
- 8,000 sq. ft. of licensed and operational cultivation/production facility in Clark County;
- Licensed 5,400 sq. ft. production laboratory in North Las Vegas with UPLC and GC testing capabilities; and
- Approved 8.9-acre cultivation license in North Las Vegas that’s ready to move to a new high-tech green house facility.
- Expansion capacity to cultivate and process over 45,440 pounds of cannabis annually.
Green Therapeutics has also applied for retail cannabis licenses in several locations throughout the State.
Terms of the Transaction
Upon receipt of regulatory approval, Nutritional High will acquire the 75% interest in Green Therapeutics on the following basis:
- Purchase price of $18 million, paid as follows (all figures in $ USD):
– Nutritional High to invest $6,600,000 in Green Therapeutics for expansion and growth, including the building of a 43,800 square foot cultivation facility on the 8.9-acre Property. The $6,000,000 investment will be advanced in tranches over 18 months;
– $4,000,000 in Nutritional High shares issuable at a price (the “Issuance Price”) which is the lesser of (i) $0.27 per share, or (ii) the 20-day VWAP price of Nutritional High shares on the Canadian Securities Exchange, converted into United States dollars, on the day that is three (3) business days prior to the Closing Date;
– $7,400,000 in convertible debt (“Notes”) convertible at a price per share equal to a 20% premium to the Issuance Price, $3,400,000 of which shall mature 12 months from closing, and $4,000,000 of which shall mature 24 months from closing.
- Concurrent with the closing of the Acquisition, the Company will purchase the Property from Meridian for the sum of $1,519,000, being the original cost of the land to the vendors. This property will become home to one of the largest processing facilities in Nevada and will showcase new technologies in the industry. The consideration for this land will be paid out of cash reserves.
- The Notes shall be secured by a pledge agreement encumbering the Green Therapeutics Shares purchased by Nutritional High, as well as the Property.
- Nutritional High to secure the intellectual property rights to Green Therapeutics’ “Provisions” and “Tsunami” brand of products (excepting certain rights in the State of Michigan).
- Nutritional High shall have an option to acquire the remaining 25% of Green Therapeutics shares at any time after the payment or conversion of the Notes for (i) $7,500,000 if the Option Notice is sent on or before the second anniversary of the Closing; or thereafter (ii) the greater of (a) $7,500,000 or (b) the trailing twelve (12) month EBITA of the Company, multiplied by seven (7), multiplied by 25%. The purchase price will be paid in cash, or at the election of the Vendors, half in shares of Nutritional High.
- The Vendors have a right to require Nutritional High to buy their 25% remaining interest in Green Therapeutics at any time after the second anniversary after the Closing at a price equal to the trailing twelve-month EBITA of the Company immediately preceding the date of the exercise of the Put, multiplied by seven, multiplied by 25%. If the Put is exercised, the purchase price will be paid half in cash and half in shares of Nutritional High.
In the preceding months, the Company and Green Therapeutics have been collaborating to determine optimal product and production strategies to be implemented at Green Therapeutics’ Nevada cultivation and processing facility, as well as the Company’s other markets. In addition, the management of both companies have been working on refining the strategy of how Nutritional High and Green Therapeutics will roll-out in the Nevada market after the Acquisition is closed.